Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inmode Ltd (NQ: INMD )

19.05 +0.56 (+3.03%)
Streaming Delayed Price Updated: 2:10 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inmode Ltd

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential
There isn't much that's stopping them from penetrating their markets globally. 
Via The Motley Fool
Target, InMode, Wynn Resorts And This US Bank Is A 'Favorite' In Financial Sector: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management said InMode Ltd. (NASDAQ: INMD) trades at 13 times next year's earnings. 
Via Benzinga
2 High-Growth Stocks That Could Double Your Money in 5 Years or Less
Both are likely to double quite soon, and they aren't even that risky. 
Via The Motley Fool
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023
Both have growth catalysts on the way, and plenty of recurring revenue too. 
Via The Motley Fool
3 Under-the-Radar Growth Stocks with Promising Fundamentals
Maximize your chances of success in the stock market by investing in these under-the-radar growth stocks that are trading at a discount. 
Via InvestorPlace
InMode (INMD) Q4 2022 Earnings Call Transcript
INMD earnings call for the period ending December 31, 2022. 
Via The Motley Fool
InMode Slumps On Light Earnings Outlook Despite Quarterly Beat
The company continued its trend of beating already strong quarterly expectations. 
Via Investor's Business Daily
3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023
Analysts' price targets for this stock suggest it could soon put up some big gains. 
Via The Motley Fool
InMode Stock: Bull vs. Bear
There are two sides of the coin with this healthcare stock. 
Via The Motley Fool
Analyst Says M&A Could Be A Negative Catalyst For This Aesthetic Company
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023
Via Benzinga
2 Terrific Growth Stocks to Buy With $200 Right Now
You don't have to be rich to get your money to start working for you. 
Via The Motley Fool
InMode Stock Dropped 9% Today
Revenue in 2023 is expected to grow much slower than it has in recent years. 
Via The Motley Fool
Better Medtech Stock to Buy: InMode or Outset Medical?
Here are the "ins and outs" for these two stocks. 
Via The Motley Fool
InMode's Q4 Earnings Surpass Expectations, Issues Mixed FY23 Guidance
Via Benzinga
What's Going On With InMode Stock Today?
InMode Ltd (NASDAQ: INMD) shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings f 
Via Benzinga
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
Find out why the investment bankers who follow these stocks think they can soar in the near term. 
Via The Motley Fool
3 No-Brainer Growth Stocks to Buy in 2023
These stocks all fell by double digits last year. 
Via The Motley Fool
'I Think You Should Take The Money And Run': Cramer On This Stock Up 52% Over Past Month
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ: FOLD) is an "ideal spec. 
Via Benzinga
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion. 
Via Benzinga
2 Promising New Growth Stocks to Watch in 2023
These stocks have plenty of room to run. 
Via The Motley Fool
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better. 
Via Investor's Business Daily
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. 
Via The Motley Fool
Got $3,000? 3 Growth Stocks to Double Up On Right Now
With these growth stocks down between 25% and 38% over the last year, it may be time to add to them as they widen their moats. 
Via The Motley Fool
7 Must-Buy Nasdaq Stocks to Kick Off the First Quarter
With the macro picture improving and growth stocks rebounding so far this year, investors should look for excellent Nasdaq stocks to buy. 
Via InvestorPlace
3 Top Growth Stocks That Could Shoot 39% to 95% Higher in 2023 According to Wall Street
Find out why the investment bank analysts who follow these stocks have such high hopes. 
Via The Motley Fool
Buy Shares of This Supercharged Growth Stock Today to Beat the Market in 2023
InMode's growth is ramping up, and its valuation is on the cheap side, too. 
Via The Motley Fool
3 Explosive Growth Stocks to Buy Now That Could Rocket Higher in 2023
The stock market can't ignore forever how quickly these businesses are growing. 
Via The Motley Fool
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
More Likely to 5X First: CRISPR Therapeutics vs. InMode
These two companies are in very different situations but could generate significant returns for investors. 
Via The Motley Fool
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.